Previous 10 | Next 10 |
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. An accelerating rotation into value stocks in the small c...
SAN FRANCISCO, April 22, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the first quarter 2021 after the close of tradi...
iRhythm Technologies' future operating model is in jeopardy following Novitas' recent announcement on ECG reimbursement rates. Around 27% of total sales is exposed to Medicare for iRhythm, thus ~30% of the top line remains unhedged to the downside going forward. Shares have given ...
Reimbursement code changes to Current Procedural Terminology codes 93243 and 93247 are finalized. The changes decrease reimbursement for the Zio XT and AT patches by roughly 80%. iRhythm initial estimates of the impact on business following this change do not take into consideration t...
Shares of iRhythm Technologies Inc. (NASDAQ:IRTC) traded today at $77.51, breaking its 52-week low. Approximately 557,000 shares have changed hands today, as compared to an average 30-day volume of 670,000 shares. iRhythm Technologies Inc. has overhead space with shares priced $85.30, or...
iRhythm continues to trade lower as analysts evaluate the impact of Novitas rate update on the company. Meanwhile, the recent FDA approvals have led Truist Securities to upgrade Bristol Myers.iRhythm downgraded at BTIG on uncertain outlookThe revision of Novitas reimbursement rates ...
iRhythm Technologies (IRTC) was cut to neutral from overweight at JPMorgan after the shares plunged 38% as Novitas published updated reimbursement codes for a heart monitoring device that were materially below investors expectations.The Novitas new rates are "highly disappointing" a...
Gainers: Wilhelmina International (WHLM) +44%.180 Life Sciences (ATNF) +28%.Evelo Biosciences (EVLO) +24%.Celcuity (CELC) +19%.Taysha Gene Therapies (TSHA) +17%.Nuance Communications (NUAN) +16%.Tiziana Life Sciences (TLSA) +15%.PLBY Group (PLBY) +13%.Pintec Technology (PT) +13%.Aur...
Shares of iRhythm Technologies (NASDAQ: IRTC) were crashing 37.5% lower as of 12:01 p.m. EDT on Monday. The big decline came after the company responded to the publication of Medicare reimbursement rates by Novitas Solutions on Saturday. iRhythm stated that these new rates would...
Gainers: Evelo Biosciences (EVLO) +26%, Ikena Oncology (IKNA) 21%, Taysha Gene Therapies (TSHA) +19%, 180 Life Sciences (ATNF) +16%, Tiziana Life Sciences (TLSA) +14%.Losers: iRhythm Technologies (IRTC) -38%, Biophytis (BPTS) -25%, Greenw...
News, Short Squeeze, Breakout and More Instantly...
iRhythm Technologies Inc. Company Name:
IRTC Stock Symbol:
NASDAQ Market:
iRhythm Technologies Inc. Website:
SAN FRANCISCO, July 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2024 ...
2024-06-20 06:30:05 ET Wolfe Research analyst issues OUTPERFORM recommendation for IRTC on June 20, 2024 05:01AM ET. IRTC was trading at $98.16 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Strong B...
SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company has successfully launched the initial phases of it...